Sugarloaf Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-15
| Closed | -$208 | – | 683 |
|
|
2024
Q1 | $208 | Hold |
15
| – | – | ﹤0.01% | 653 |
|
|
2023
Q4 | $214 | Hold |
15
| – | – | ﹤0.01% | 661 |
|
|
2023
Q3 | $232 | Hold |
15
| – | – | ﹤0.01% | 661 |
|
|
2023
Q2 | $236 | Hold |
15
| – | – | ﹤0.01% | 669 |
|
|
2023
Q1 | $247 | Hold |
15
| – | – | ﹤0.01% | 673 |
|
|
2022
Q4 | $234 | Hold |
15
| – | – | ﹤0.01% | 755 |
|
|
2022
Q3 | $1K | Hold |
15
| – | – | ﹤0.01% | 792 |
|
|
2022
Q2 | $0 | Hold |
15
| – | – | ﹤0.01% | 816 |
|
|
2022
Q1 | $0 | Hold |
15
| – | – | ﹤0.01% | 763 |
|
|
2021
Q4 | $0 | Hold |
15
| – | – | ﹤0.01% | 778 |
|
|
2021
Q3 | $0 | Hold |
15
| – | – | ﹤0.01% | 795 |
|
|
2021
Q2 | $0 | Hold |
15
| – | – | ﹤0.01% | 777 |
|
|
2021
Q1 | $0 | Hold |
15
| – | – | ﹤0.01% | 777 |
|
|
2020
Q4 | $0 | Hold |
15
| – | – | ﹤0.01% | 746 |
|
|
2020
Q3 | $0 | Hold |
15
| – | – | ﹤0.01% | 715 |
|
|
2020
Q2 | $0 | Hold |
15
| – | – | ﹤0.01% | 723 |
|
|
2020
Q1 | $0 | Hold |
15
| – | – | ﹤0.01% | 749 |
|
|
2019
Q4 | $0 | Buy |
+15
| New | – | ﹤0.01% | 723 |
|